Fig. S1. A microfluidic device containing cell-trapping microstructures for high-throughput analysis of single-cell infections. (a) Organization of microfluidic device into five sections of 1140 (12×95) microwells permits five independent experiment to be performed on each device. (b) Shown below is an image of a device mounted on the stage of the microscope. [Photo Credit: Wu Liu, The Pennsylvania State University] (c) Cross-section of the microfluidic device. The microwells for cell culture, channels for cell loading, and valve channels for isolation of the microwells are ~100 µm, ~20 µm, and ~50 µm deep, respectively. (d) Influence of channel width on single-cell trapping efficiency.
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